Novalis LifeSciences is a boutique investment and advisory firm focused on the Life Science industry. Founded in 2017 by Marijn E. Dekkers, the firm funds and advises visionary Life Science entrepreneurs, typically investing in companies at critical growth stages. Novalis participates in various investment rounds, including Series A, B, C, and D, as well as Seed and Post-IPO Equity rounds.
The firm's notable portfolio includes companies like AgBiome, Enko, Vizgen, and Sherlock Biosciences. Key partners bring extensive industry experience, with Marijn E. Dekkers previously serving as CEO of Bayer AG. Novalis offers strategic and operational advice through its advisory arm, enhancing the growth potential of its portfolio companies beyond mere financial investment.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
